首页|艾司氯胺酮与舒芬太尼联合右美托咪定在经皮椎体成形术中的应用效果比较

艾司氯胺酮与舒芬太尼联合右美托咪定在经皮椎体成形术中的应用效果比较

扫码查看
目的 比较艾司氯胺酮与舒芬太尼联合右美托咪定在老年患者经皮椎体成形术中的镇痛、镇静效果及安全性.方法 采用前瞻性研究方法,将60例择期行椎体成形术患者随机分为SD组(舒芬太尼+右美托咪定组,n=30)和KD组(艾司氯胺酮+右美托咪定组,n=30).SD组给予0.1μg·kg-1舒芬太尼静脉注射,KD组给予艾司氯胺酮0.3 mg·kg-1静脉注射,随后均给予右美托咪定0.5μg·kg-1·h-1持续泵注.比较2组T1(给药前)、T2(给予舒芬太尼或艾司氯胺酮后5 min)、T3(给予舒芬太尼或艾司氯胺酮后15 min)、T4(给予舒芬太尼或艾司氯胺酮后30 min)、T5(出手术室前)5个时间点的平均动脉压(MAP)、心率(HR)、血氧饱和度(SPO2)、疼痛程度VAS评分及Ramsay镇静评分;观察2组患者的不良反应,包括血压波动、心律失常、呼吸抑制、恶心呕吐及呓语躁动精神症状等.结果 与SD组相比,KD组T3、T4时间点MAP及HR显著升高,T2、T3、T4时间点Ramsay镇静评分显著升高,T3、T4时间点VAS疼痛评分显著降低,差异均有统计学意义(P<0.05).2组不良反应发生率比较差异无统计学意义(P>0.05).结论 在经皮椎体成形术中采用小剂量艾司氯胺酮与右美托咪定联合能够产生良好的镇痛镇静效果,生命体征更加平稳,是一种安全可行的麻醉用药组合.
Comparison of the Efficacy of Ketamine and Sufentanil Combined with Dexmedetomidine in Percutaneous Vertebroplasty
Objective To compare the efficacy of esketamine versus sufentanil combined with dexmedetomidine on intravenous analgesia,sedation and safety in elderly patients undergoing per-cutaneous vertebroplasty(PVP).Methods Using prospective research methods,Sixty elderly pa-tients who underwent PVP with osteoporosis vertebral compression fracture were assigned ran-domly into SD group(sufentanil+dexmedetomidine group,n=30)and KD group(esketamine+dexmedetomidinegroup,n=30).SD group was given 0.1 μg·kg-1intravenous injection,and KD group was given esketamine 0.3 mg·kg-1intravenous injection,followed by dexmedetomidine 0.5 µg·kg-1·h-1 continuous pumping in both.Compare the mean arterial pressure(MAP),heart rate(HR),blood oxygen saturation(SPO2),pain level VAS score and Ramsay sedation score of the 2 groups at 5 time points:T1(before drug administration),T2(5 min after administration of sufentanil or esketamine),T3(15 min after administration of sufentanil or esketamine),T4(30 min after administration of sufentanil or esketamine),and T5(before discharge from the op-erating room);and observe the adverse effects of the patients in 2 groups,including blood pres-sure fluctuation,cardiac arrhythmia,respiratory depression,nausea and vomiting,psychotic symp-toms such as balderdash and agitation.Results Compared with SD group,KD group had signifi-cantly higher MAP and HR at T3 and T4,significantly higher Ramsay sedation scores atT2,T3,and T4,and significantly lower VAS pain scores at T3 and T4,and the differences were all statis-tically significant(P<0.05).There was no significant difference in the incidence of adverse reac-tions between the two groups(P>0.05).Conclusion Low-dose esketamine combined with dexmedetomidine in percutaneous vertebroplasty may produce good analgesia and sedation,with smoot-her vital signs,and may be a clinically safe and feasible combination of anesthesia medications.

esketaminesufentanildexmedetomidinepercutaneous vertebroplasty

李晓丽、卜令标、巩岩、孙大为

展开 >

邹城市人民医院麻醉科,山东邹城 273500

艾司氯胺酮 舒芬太尼 右美托咪定 经皮椎体成形术

2024

实用临床医学
南昌大学

实用临床医学

影响因子:0.818
ISSN:1009-8194
年,卷(期):2024.25(1)
  • 14